Vitamin D

Clinical Reviews in Bone and Mineral Metabolism

Volumn 1, Issue 3-4, 2002, Pages 181-207

  Holick, Michael F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25 hydroxyvitamin D; Bone; Cancer; Sunlight; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; COLECALCIFEROL; PHOSPHORUS; RENIN; SUNSCREEN; VITAMIN D;

AGING; BONE DEVELOPMENT; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM BONE LEVEL; CALCIUM MOBILIZATION; CANCER; CELL PROLIFERATION; CHRONIC DISEASE; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; DOWN REGULATION; HEART DISEASE; HYPERTENSION; IMMUNOMODULATION; MILK; ORANGE JUICE; OSTEOBLAST; OSTEOCLAST; PHOSPHATE BLOOD LEVEL; REVIEW; SKIN PIGMENTATION; STEM CELL; SUN EXPOSURE; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN METABOLISM;

EID: 0345170655     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:1:3-4:181     Document Type: Review

References (104)

1. Holick MF. 1989 Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Vertebrate Endocrinology: Fundamentals and Biomedical Implications, Vol. 3., Pang PKT, and Schreibman MP, eds. Academic, Orlando, FL, 7-43.
2. Holick MF. Calcium and vitamin D in human health. Annales Nestlé, in press.
3. Holick MF. 2003 Vitamin D: a millennium perspective. J Cell Biochem 88:296-307.
4. Cooke NE, David EV. 1985 Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 76:2420-2424.
5. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693.
6. Holick MF. 2001 Evaluation and treatment of disorders in calcium, phosphorus, and magnesium metabolism. In: Textbook of Primary Care Medicine, 3rd ed. Noble J, ed. Mosby, St. Louis, 100:886-898.
7. Bouillon R. 2001 Vitamin D: from photosynthesis, metabolism, and action to clinical applications. In: Endocrinology. DeGroot LJ, Jameson JL, eds. Saunders, Philadelphia, 1009-1028.
8. 3. Cell 96:507-515.
9. MacDonald PN. 1999 Molecular biology of the vitamin D receptor. In: Vitamin D: Physiology, Molecular Biology and Clinical Applications. Holick MF, ed. Humana, Totowa, NJ, 109-128.
10. Holick, MF. 1999 Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed. Favus MJ, ed. Lippincott-Raven, Philadelphia, 92-98.
11. Freedman LP. 1999 Multimeric coactivator complexes for steroid/nuclear receptors. Trends Endocrinol Metabol 10:403-407.
12. 3 on intestinal calcium absorption and renal calcium transport. In: Vitamin D: Physiology, Molecular Biology and Clinical Applications. Holick MF, ed. Humana, Totowa, NJ, 163-173.
13. Khosla S. 2001 The OPG/RANKL/RANK system. Endocrinology 142:5050-5055.
14. Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, et al. 1996 Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137:2187-2190.
15. Holick MF. 2002 Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9:87-98.
16. 3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 60:615-617.
17. Lian JB, Staal A, van Wijnen JA., Stein JL, Stein GS. 1999 Biologic and molecular effects of vitamin D on bone. In: Vitamin D: Physiology, Molecular Biology, and Clinical Applications. Holick MF, ed. Humana, Totowa, NJ, 175-193.
18. Underwood JL, DeLuca HF. 1984 Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol 246:E493-E498.
19. Holtrop ME, Cox KA, Carnes DL, Holick MF. 1986 Effects of serum calcium and phosphorus on skeletal mineralization in vitamin D-deficient rats. Am J Physiol 251(2 pt 1):E234-E240.
20. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, et al. 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77:1661-1667.
21. Steenbock H. 1924 The induction of growth-prompting and calcifying properties in a ration exposed to light. Science 60:224-225.
22. Holick MF. 2001 Vitamin D: importance for bone health, cellular health and cancer prevention. In: Biologic Effects of Light 2001. Holick MF, ed. Kluwer, Boston, 155-173.
23. Oppé TE. 1964 Infantile hypercalcemia, nutritional rickets, and infantile survey in Great Britain. Br Med J 1:1659-1661.
24. Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. 2003 Fortification of orange juice with vitamin D: a novel approach to enhance vitamin D nutritional health. Am J Clin Nutr 77:1478-1483.
25. 3 and its photo isomers in human skin. Science 1001-1003.
26. 3 in the skin of poikilothermic animals. Proc Natl Acad Sci USA 92(8):3124-3126.
27. 3 in human skin. J Biol Chem 268(20):14888-14892.
28. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. 1993 Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91:2552-2555.
29. 3. Lancet 74-76.
30. 3 synthesis. J Clin Endocrinol Metab 64:1165-1168.
31. 3. J Clin Endocrinol Metab 75(4):1099-1103.
32. Taha SA, Dost SM, Sedrani SH. 1984 25-Hydroxyvitamin D and total calcium: extraordinarily low plasma concentrations in Saudi mothers and their neonates. Pediatr Res 18:739-741.
33. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, et al. 2000 Hypovitaminosis D myopathy without osteomalacic bone involvement. Calcif Tissue Int 66(6):419-424.
34. Holick, M.F. 1994 McCollum Award Lecture, 1994: Vitamin D: new horizons for the 21st century. Am J Clin Nutr 60:619-630.
35. 3. J Clin Invest 76:1536-1538.
36. Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YHW, Riccardi D, et al. 1995 Calcium-ion-sensing cell-surface receptors. N Engl J Med 333:234-240.
37. Jüppner H, Brown EM, Kronenberg HM. 1999 Parathyroid hormone. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed. Favus MJ, ed. Lippincott-Raven, Philadelphia, 80-87.
38. Hordon LD, Peacock M. 1990 Osteomalacia and osteoporosis in femoral neck fracture. Bone Miner 11:247-259.
39. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1627-1642.
40. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
41. Schnitzler CM, Solomon L. 1983 Osteomalacia in elderly White South African women with fractures of the femoral neck. S Afr Med J 64:527-530.
42. Al-Ali H, Fuleihan GEH. 2000 Nutritional osteomalacia: substantial clinial improvement and gain in bone density post-therapy. J Clin Densitometr 3:97-101.
43. Malabanan AO, Turner AK, Holick MF. 1998 Severe generalized bone pain and osteoporosis in a premenopausal black female: effect of vitamin D replacement. J Clin Densitometr 1:201-204.
44. Holick MF. 2002 Sunlight and vitamin D, both good for cardiovascular health (editorial). J Gen Intern Med 17:733-735.
45. Rimaniol J, Authier F, Chariot P. 1994 Muscle weakness in intensive care patients: initial manifestation of vitamin D deficiency. Intensive Care Med 20:591-592.
46. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, et al. 2003 Effect of vitamin D and calcium supplementation on falls: a randomized controlled study. J Bone Miner Res 18(2):343-351.
47. Gloth FM, Gundberg CM, Hollis BW, Haddad HG, Tobin JD. 1995 Vitamin D deficiency in homebound elderly persons. JAMA 274:1683-1686.
48. Malabanan A, Veronikis IE, Holick MF. 1998 Redefining vitamin D insufficiency. Lancet 351:805-806.
49. Lips P. 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 22(4):477-501.
50. Chapuy MC, Preziosi P, Maaner M, Arnaud S, Galan P, Hercberg S, et al. 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteopor Int 7:439-443.
51. Tangpricha V, Pearce EN, Chen TC, Holick MF. 2002 Vitamin D insufficiency among free-living healthy young adults. Am J Med 112:659-662.
52. Kreiter SR, Schwartz RP, Kirkman HN, Charlton PA, Calikoglu AS, Davenport M. 2000 Nutritional rickets in African American breast-fed infants. J Pediatr 137:2-6.
53. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 1997 Vitamin D. In: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Institute of Medicine. National Academy Press, Washington, DC, 263.
54. Welch TR. 2000 Vitamin D deficient rickets: the reemergence of a once-conquered disease. J Pediatr 137(2):143-145.
55. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783.
56. Holick MF, Shao Q, Liu WW, Chen TC. 1992 The vitamin D content of fortified milk and infant formula. N Engl J Med 326(18):1178-1181.
57. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. 1985 Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr 42:644-649.
58. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. 1996 Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 101:262-269.
59. Shike M, Harrison J, Sturtridge C, Tam CS, Bobechko PE, Jones G, et al. 1994 Metabolic bone disease in patients receiving long-term parenteral nutrition. Ann Intern Med 92:343-350.
60. Shike M, Shils ME, Heller A, Alcock N, Vigorita V, Brockman R, et al. 1986 Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. Am J Clin Nutr 44:89-98.
61. Chel VGM, Ooms ME, Popp-Snijders C, Pavel S, Schothorst AA, Meulemans CCE, et al. 1998 Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 13:1238-1242.
62. Chuck A, Todd J, Diffey B. 2001 Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photochem Photoimmun Photomed 17(4):168-171.
63. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. 1985 Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370-373.
64. 2-vitamin D concentrations in nutritional osteomalacia. Lancet 1377-1378.
65. Vieth R. 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-856.
66. 1-3. Am J Clin Nutr 73:288-294.
67. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. 1998 Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteopor Int 8:222-230.
68. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. 2003 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210.
69. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. 1999 An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9(5):394-397.
70. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier J, et al. 1996 Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129-1133.
71. Koutkia P, Chen TC, Holick MF. 2001 Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 345(1):66-67.
72. Bauer JM, Freyberg RH. 1946 Vitamin D intoxication and metastatic calcification. JAMA 1208-1215.
73. Adams JS, Lee G. 1997 Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 127:203-206.
74. Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 326:1173-1177.
75. Heikinheimo RJ, Ubjivaaram JA, Jantti PO, Maki-Jokela PL, Rajala SA, Sievanen H. 1994 Intermittant parenteral vitamin D supplementation in the elderly in nutritional aspects of osteoporosis. In: Challenges of Modern Medicine. Burckhard P, Heaney RP, eds. Ares-Serono, Geneva, Switzerland: 335-340.
76. Holick MF, Jenkins M. The UV Advantage. iBooks, New York, in press.
77. Koutkia P, Lu Z, Chen TC, Holick MF. 2001 Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 121(6):1485-1488.
78. Apperly FL. 1941 The relation of solar radiation to cancer mortality in North America. Cancer Res 1:191-195.
79. Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED. 1989 Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 18:1176-1178.
80. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Oglesby P. 1985 Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 9:307-309.
81. Garland CF, Garland FC, Gorham ED, Raffa J. 1992 Sunlight, vitamin D, and mortality from breast and colorectal cancer in Italy. In: Biologic Effects of Light. Holick MF, Kligman A, eds. Walter de Gruyter, New York, 39-43.
82. Garland FC, Garland CF, Gorham ED, Young JF. 1990 Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prevent Med 19:614-622.
83. Hanchette CL, Schwartz GG. 1992 Geographic patterns of prostate cancer mortality. Cancer 70:2861-2869.
84. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. 2000 Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847-852.
85. Grant WB. 2002 An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Am Cancer Soc 94:272-281.
86. Rostand SG. 1979 Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30:150-156.
87. Hernan MA, Olek MJ, Ascherio A. 1999 Geographic variation of MS incidence in two prospective studies of US women. Neurology 51:1711-1718.
88. 3 and its analogues in the treatment of psoriasis. Retinoids 14(1)12-17.
89. 3 production by isolated renal slices is modulated by diabetes and insulin in the rat. Diabetes 32:302-306.
90. 3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 3(10):1458-1463.
91. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374.
92. 3. Diabetologia 37:552-558.
93. Hypponen E, Laara E, Jarvelin M-R, Virtanen SM. 2001 Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500-1503.
94. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238.
95. 3 levels: a community-based study. Int J Epidemiol 19:559-563.
96. Zitterman A, Schulze Schleithoff S, Tenderich C, Berthold H, Koefer R, Stehle P. 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41(1):105-112.
97. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. 1998 Ultraviolet B and blood pressure. Lancet 352(9129):709-710.
98. Scragg R. 1981 Seasonality of cardiovascular disease mortality and the possible protective effect of utlra-violet radiation. Int J Epidemiol 10:337-341.
99. 3. Cancer Epidemiol Biomarkers Prev 7(5):391-395.
100. 3 production by human keratinocytes: kinetics and regulation. J Clin Invest 78:557-566.
101. 3 (calcitriol) in the human keratinocyte line HaCaT. Photochem Photobiol 72(6):803-809.
102. 3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287-292.
103. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, et al. 2001 25-hydroxyvitamin D-1a-hydroxylase in normal and malignant colon tissue. Lancet 357(9269):1673-1674.
104. Holick MF. 2001 Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 357:4-6.